All Articles In 'Drug Safety'
Electronic Prescribing: Benefits and Challenges of E-Prescribing
A study funded by AHRQ and published in the Journal of the American Medical Informatics Association, Transmitting and processing electronic prescriptions: Experiences of physician practices and pharmacies, identifies both the benefits and challenges with electronic prescribing [...]
Using Health Information Technology for Chronic Disease Management: AHRQ Webinar
The Agency for Healthcare Research and Quality (AHRQ) is hosting a free webinar on Using Health Information Technology for Chronic Disease Management. Webinar is set for Tuesday, June 21, 2011, at 11:30 am EST. During the 90-minute conference, participants can watch [...]
Direct-to-Consumer Advertising of Prescription Drugs: Legal, Policy, Market, and Public Health Issues for Potential Bans on DTC Advertising of New Brand Drugs
Direct-to-Consumer (DTC) advertising of prescription drugs, especially new brand-named drugs, remains controversial. Some in Congress remain eager to prohibit advertising of brand-name prescription drugs to consumers in the first two years following a drug’s approval by [...]
Pharmaceutical Research & Development in a Value-Based Healthcare System
At the last annual meeting of the Academy of Managed Care Pharmacy, several of us spoke on pharmaceutical research and development in the quickly emerging value-driven healthcare system. Topics focused on the impact of value-based benefit [...]
Management Challenges at Department of Health and Human Services: Implications for CMS and FDA Appointments
The incoming leadership at the U.S. Department of Health and Human Services (HHS) face a number of serious management challenges. These challenges, recently identified by the Office of the Inspector General (OIG), will require close, sustained [...]
Medicare Part D: Comparing Prescription Drug Use in Special Needs Plans and Other Medicare Advantage Plans
Medicare beneficiaries in Special Needs Plans (SNPs) have higher Part D prescription drug utilization and costs than enrollees in other Medicare Advantage Prescription Drug Plans (MA-PDs) do. This is no surprise since, by design, Special Needs [...]















